Reports
Louisiana's Response to COVID-19 in Nursing Facilities
Inconsistent Documentation and Management of COVID-19 Vaccinations for Community Living Center Residents
Review of Community-Based Outpatient Clinics Closed Due to the COVID-19 Pandemic
California Department of Public Health: It Could Do More to Ensure Federal Funds for Expanding the State’s COVID‑19 Testing and Contact Tracing Programs Are Used Effectively
Violations of Detention Standards Amidst COVID-19 Outbreak at La Palma Correctional Center in Eloy, AZ
Comprehensive Healthcare Inspection of Facilities' COVID-19 Pandemic Readiness and Response in Veterans Integrated Service Networks 10 and 20
Yearend Review of Opioid Use in Medicare Part D in 2020
Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.